Potential Immunotherapies for Head and Neck Cancers

Publication
Article
Special ReportsImmunotherapy (Issue 4)
Volume 4
Issue 1

Barbara Burtness, MD, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.

Barbara Burtness, MD, Clinical Research Program Leader, Head and Neck Cancers Program,Co-Director, Developmental Therapeutics Research Program,Professor of Medicine (Medical Oncology), Yale Cancer Center, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.

<<<

Recent Videos
Related Content